BOLD vs IRM · P/E 0.1, $24.6M cap vs P/E 136, rev $6.15B
Boundless Bio, Inc. Common Stock (BOLD) versus Iron Mountain Incorporated (IRM) — a side-by-side from cached financials, not a winner call.
Boundless Bio, Inc. Common Stock (BOLD) is a biotechnology company listed on US.
Iron Mountain Incorporated (IRM) is a reit - specialty company listed on US.
BOLD does not have a complete income-statement cache yet.
Latest reported IRM revenue for 2024-12-31 was $6.15B. Net income was $183.7M. Revenue was up 12.2% from 2023-12-31 to 2024-12-31. IRM currently screens at market cap $37.09B and trailing P/E 135.5.
BOLD currently screens at market cap $24.6M and trailing P/E 0.1. IRM currently screens at market cap $37.09B and trailing P/E 135.5.
Not investment advice. Open the BOLD and IRM stock pages for the full models.
Not investment advice.